SCHEMBL31335946

SCHEMBL31335946

CC1(C)CNc2cc(O)c(C(=O)O)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 7/20 0.42
RARB P10826 6/20 0.40
AR P10275 1/20 0.38
RARG P13631 6/20 0.36
RARA P10276 5/20 0.36
CSNK2A1 P68400 1/20 0.36
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA7 P43166 2/20 0.34
CA9 Q16790 2/20 0.34
CA14 Q9ULX7 2/20 0.34
ALOX5 P09917 1/20 0.34
PTGS2 P35354 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
RXRB P28702 2/20 0.34
RXRG P48443 2/20 0.34
MCL1 Q07820 2/20 0.33
GRM1 Q13255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25155975 0.81 RXRA (0.43) RXRARARBARRARGRARA
SCHEMBL30701833 0.74 RXRA (0.69) RXRARARBRARGRARARXRB
SCHEMBL7149480 0.74 RXRA (0.69) RXRARARBRARGRARARXRB
SCHEMBL31456579 0.72 RARB (0.53) RXRARARBRARGRARAALDH1A1
SCHEMBL31335589 0.72 ATAD2 (0.42) RXRARARBCSNK2A1CA12CA1
SCHEMBL31335591 0.72 ATAD2 (0.42) RXRARARBCSNK2A1CA12CA1
SCHEMBL21026575 0.71 RXRA (0.45) RXRARARBRARGRARACSNK2A1
SCHEMBL31335734 0.70 GAA (0.42) RXRARARBARRARGRARA
SCHEMBL25156171 0.68 MAPT (0.39) RXRARARBARRARGRARA
SCHEMBL10828177 0.67 MRGPRX2 (0.37) RARBARRARGALDH1A1CIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720038-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2026-04-08 EP disclosed
WO-2024246496-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2024-12-05 WO disclosed